TY  - GEN
AU  - Zhang,Xin
AU  - Tao,Yazhong
AU  - Chopra,Manisha
AU  - Ahn,Mihye
AU  - Marcus,Karen L
AU  - Choudhary,Neelima
AU  - Zhu,Hongtu
AU  - Markovic-Plese,Silva
TI  - Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis
SN  - 1550-6606
PY  - 2014///0218
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, Differentiation, T-Lymphocyte
KW  - analysis
KW  - Antigens, Neoplasm
KW  - CD52 Antigen
KW  - Cells, Cultured
KW  - Clinical Trials, Phase III as Topic
KW  - Glycoproteins
KW  - Humans
KW  - Immunologic Memory
KW  - drug effects
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - Interleukin-7
KW  - Lymphocyte Depletion
KW  - methods
KW  - Lymphokines
KW  - blood
KW  - Lymphopenia
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - T-Lymphocyte Subsets
KW  - chemistry
KW  - Th1 Cells
KW  - pathology
KW  - Th17 Cells
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4049/jimmunol.1301926
ER  -